Dr. Meraj Neyazi

• 
• 

Meraj Neyazi earned his medical degree from Hannover Medical School and completed clinical rotations at the Medical University of Vienna and Nara Medical University in Japan. As a medical student in the Seidman Laboratories at Harvard Medical School, he identified a conserved enhancer in titin’s first intron that regulates TTN expression, opening new avenues for gene therapy in dilated cardiomyopathy. After beginning cardiology training in Hamburg, he applied deep-learning algorithms to ECG data to improve population-level cardiovascular risk assessment. He then spent three years in the Seidman Laboratories as a postdoctoral fellow, supported by the German Research Foundation, where he used state-of-the-art sequencing methods to delineate the molecular basis of hypertrophic cardiomyopathy, cardiac sarcoidosis, and chemotherapy-associated heart disease, and refined CRISPR-based therapeutic strategies for inherited cardiac disorders. He has now returned to the Department of Cardiology at the University Heart and Vascular Center Hamburg as a physician-scientist, continuing his clinical training while pursuing translational research to deepen understanding of cardiovascular disease and enhance patient care.

• 
• 

m.neyazi@uke.de

Publications please visit PubMed